Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets.

The L-type Ca2+ channels mediate depolarization-induced influx of Ca2+ into a wide variety of cells and thus play a central role in triggering cardiac and smooth muscle contraction. Because of this role, clinically important classes of 1,4-dihydropyridine, phenylalkylamine, and benzothiazepine Ca2+ channel blockers were developed as powerful medicines to treat hypertension and angina pectoris. Molecular cloning studies revealed that the channel is subject to extensive structure-functional variability due to alternative splicing. In this review, we will focus on a potentially important role of genetically driven variability of Ca2+ channels in expression regulation and mutations, Ca2+-induced inactivation, and modulation of sensitivity to Ca2+ channel blockers with the perspective for new pharmacological targets.
AuthorsDarrell R Abernethy, Nikolai M Soldatov
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 300 Issue 3 Pg. 724-8 (Mar 2002) ISSN: 0022-3565 [Print] United States
PMID11861774 (Publication Type: Journal Article, Review)
Chemical References
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Dihydropyridines
  • Amino Acid Sequence
  • Animals
  • Calcium Channel Blockers (pharmacology)
  • Calcium Channels, L-Type (chemistry, drug effects, genetics, metabolism)
  • Dihydropyridines (chemistry, pharmacology)
  • Genome
  • Humans
  • Molecular Sequence Data
  • Promoter Regions, Genetic
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: